marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-09-2024
Edesa Biotech Balance Sheet 2011-2024 | EDSA
Annual Balance Sheet Edesa Biotech
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-7.74 M | -7.05 M | -5.03 M | -4.23 M | -4.57 M | -7.42 M | -3.96 M | -13.4 M | -7.86 M | -999 K | -4.15 M | ||
Long Term Debt |
19.8 K | - | 20.5 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
74.7 K | 19 K | 78.8 K | 69.7 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 2.6 M | - | - | - | - | - | 5.35 M | 7.75 M | 130 K | - |
Total Current Liabilities |
1.82 M | 2.14 M | 1.46 M | 1.53 M | 462 K | 493 K | 321 K | 624 K | 2.38 M | 1.42 M | - | - | - |
Total Liabilities |
1.84 M | 2.18 M | 1.53 M | 4.13 M | 462 K | 493 K | 321 K | 624 K | 2.38 M | 6.77 M | 11.7 M | 692 K | 159 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | 173 K | 15 K | - | 127 K | - |
Retained Earnings |
-52.4 M | -44 M | -26.5 M | -13.1 M | -6.73 M | -50.4 M | -45.4 M | -40.4 M | -35.3 M | -33.6 M | -25.2 M | -10.3 M | -8.09 M |
Total Assets |
8.89 M | 11.6 M | 14.6 M | 10.8 M | 5.72 M | 11.8 M | 7.72 M | 12.9 M | 10.4 M | 14.5 M | 8.51 M | 1.54 M | 4.75 M |
Cash and Cash Equivalents |
5.4 M | 7.09 M | 7.84 M | 7.21 M | 5.03 M | 3.37 M | 4.57 M | 7.42 M | 3.96 M | 8.77 M | 7.86 M | 999 K | - |
Book Value |
7.05 M | 9.39 M | 13.1 M | 6.63 M | 5.26 M | 11.3 M | 7.4 M | 12.3 M | 8.01 M | 7.7 M | -3.14 M | 852 K | 4.59 M |
Total Shareholders Equity |
7.05 M | 9.39 M | 13.1 M | 6.63 M | 5.26 M | 3.21 M | 7.4 M | 12.3 M | 8.01 M | 10.5 M | -2.2 M | 902 K | - |
All numbers in USD currency
Quarterly Balance Sheet Edesa Biotech
| 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 19.8 K | 40.1 K | 64.4 K | 76.6 K | - | - | - | - | 20.5 K | 41.7 K | 20.5 K | 79.9 K | 94.5 K | 94.5 K | 94.5 K | 152 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.36 M | 1.99 M | 1.84 M | 1.57 M | 1.67 M | 1.4 M | 2.18 M | 5.7 M | 3.38 M | 1.79 M | 1.53 M | 1.07 M | 1.53 M | 1.03 M | 1.65 M | 1.65 M | 1.65 M | 856 K | 462 K | 462 K | 462 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.38 M | 1.78 M | 2.9 M | 4.19 M | 4.36 M | 4.36 M | 4.36 M | - | 10.7 M | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 80 K | 80 K | - | - | - | - | - | - | - | - | - | 173 K | 173 K | - | 173 K | 173 K | 173 K | 86.7 K | 86.7 K | 86.7 K | 86.7 K | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-57.6 M | -54.1 M | -52.4 M | -50.7 M | -48.7 M | -46.4 M | -44 M | -41.2 M | -35.4 M | -30.9 M | -26.5 M | -22.8 M | -26.5 M | -15.8 M | -13.1 M | -13.1 M | -13.1 M | -7.83 M | -6.73 M | -6.73 M | -6.73 M | -3.76 M | -50.4 M | -3.76 M | -51.8 M | -46.8 M | -45.4 M | -45.4 M | -45.4 M | -41.8 M | -40.4 M | -40.4 M | -40.4 M | -37 M | -35.3 M | -35.3 M | -35.3 M | -33.8 M | -32.5 M | -32.5 M | -32.5 M | - | -25.2 M | - | - | - | - | - | - | - | - | - | - |
Total Assets |
5.23 M | 7.83 M | 8.89 M | 9.42 M | 10.7 M | 11.7 M | 11.6 M | 17.5 M | 20.4 M | 12.3 M | 14.6 M | 16.9 M | 14.6 M | 10.3 M | 10.8 M | 10.8 M | 10.8 M | 5.09 M | 5.72 M | 5.72 M | 5.72 M | 3.4 M | 11.8 M | 3.4 M | 10.5 M | 6.59 M | 7.72 M | 7.72 M | 7.72 M | 11.5 M | 12.9 M | 12.9 M | 12.9 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 13.4 M | 14.8 M | 14.8 M | 14.8 M | - | 16.1 M | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
2.04 M | 4.27 M | 5.36 M | 6.46 M | 7.47 M | 8.27 M | 7.09 M | 12.8 M | 15.9 M | 5.88 M | 7.84 M | 8.05 M | 7.84 M | 6.31 M | 7.21 M | 7.21 M | 6.31 M | 3.83 M | 5.03 M | 5.03 M | 3.83 M | 3.37 M | 3.73 M | 3.37 M | 7.36 M | 5 M | 4.57 M | 4.57 M | 4.37 M | 5.89 M | 7.42 M | 7.42 M | 5.89 M | 3.89 M | 3.96 M | 3.96 M | 3.89 M | 7.76 M | 8.77 M | 13.8 M | 12.8 M | 16.7 M | 15.5 M | - | - | - | 999 K | - | - | - | 4.15 M | - | - |
Book Value |
2.87 M | 5.84 M | 7.05 M | 7.85 M | 9 M | 10.3 M | 9.39 M | 11.8 M | 17 M | 10.5 M | 13.1 M | 15.8 M | 13.1 M | 9.26 M | 9.11 M | 9.11 M | 9.11 M | 4.23 M | 5.26 M | 5.26 M | 5.26 M | 3.4 M | 11.8 M | 3.4 M | 10.5 M | 6.59 M | 7.72 M | 7.72 M | 7.72 M | 11.5 M | 12.9 M | 12.9 M | 12.9 M | 10.4 M | 8.01 M | 8.61 M | 7.48 M | 9.24 M | 10.5 M | 10.5 M | 10.5 M | - | 5.36 M | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
2.87 M | 5.84 M | 7.05 M | 7.85 M | 9 M | 10.3 M | 9.39 M | 11.8 M | 17 M | 10.5 M | 13.1 M | 15.8 M | 10.5 M | 7.89 M | 6.63 M | 7.89 M | 7.89 M | 4.23 M | 5.26 M | 4.23 M | 4.23 M | 3.21 M | 3.55 M | 3.21 M | 9.91 M | 5 M | 7.4 M | 7.4 M | 6.02 M | 10.9 M | 12.3 M | 12.3 M | 12.3 M | 9.63 M | 8.01 M | 8.01 M | 8.01 M | 9.24 M | 10.5 M | 10.5 M | 10.5 M | - | 6.54 M | - | - | - | 902 K | - | - | - | 3.44 M | - | - |
All numbers in USD currency